Combining vitamin C and carotenoid biomarkers better predicts fruit and vegetable intake than individual biomarkers in dietary intervention studies by McGrath, Alanna J. et al.
Combining vitamin C and carotenoid biomarkers better predicts
fruit and vegetable intake than individual biomarkers in dietary
intervention studies
McGrath, A. J., Hamill, L. L., Cardwell, C. R., Draffin, C. R., Neville, C. E., Appleton, K. M., ... Woodside, J. V.
(2016). Combining vitamin C and carotenoid biomarkers better predicts fruit and vegetable intake than individual
biomarkers in dietary intervention studies. European Journal of Nutrition, 55(4), 1377-1388. DOI:
10.1007/s00394-015-0953-7
Published in:
European Journal of Nutrition
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© Springer-Verlag Berlin Heidelberg 2015
The final publication is available at Springer via http://dx.doi.org/10.1007%2Fs00394-015-0953-7
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
1 
 
Combining vitamin C and carotenoid biomarkers better predicts fruit and vegetable intake than 
individual biomarkers in dietary intervention studies 
 
Alanna J McGrath1, Lesley L Hamill1, Chris R Cardwell1, Claire R Draffin1, Charlotte E Neville1, 
Katherine M Appleton2, Jane McEneny1, Michelle C McKinley1, Ian S Young1, Jayne V Woodside1* 
 
1Centre for Public Health, Queen’s University Belfast, UK (AJM, LLH, CRC, CRD, CEN, JM, MCM, 
ISY, JVW) 
2Department of Psychology, Bournemouth University, UK (KMA) 
 
Running title: Biomarkers of fruit and vegetable intake 
 
Author list for indexing: McGrath, Hamill, Cardwell, Draffin, Neville, Appleton, McEneny, 
McKinley, Young, Woodside 
 
Supported by the Medical Research Council as part of grant G0901793.  Clinical trial registration 
number NCT01591057 (www.clinicaltrials.gov) 
*corresponding author; Jayne Woodside; Centre for Public Health, First Floor, Institute of Clinical 
Science B, Grosvenor Road, Belfast, BT12 6BJ; tel 00442890 632585; fax 00442590 235900; 
j.woodside@qub.ac.uk 
 
Abbreviations used: FV – fruit and vegetables
  1 
2 
 
Abstract  2 
Purpose: The aim of this study was to determine whether combining potential biomarkers of fruit and 3 
vegetables is better at predicting FV intake within FV intervention studies than single biomarkers. 4 
Design: Data from a tightly controlled randomised FV intervention study (BIOFAV; all food provided 5 
and two meals/d on weekdays consumed under supervision) were used.  A total of 30 participants 6 
were randomised to either 2, 5 or 8 portions FV/d for four weeks, and blood samples were collected at 7 
baseline and four weeks for plasma vitamin C and serum carotenoid analysis.  The combined 8 
biomarker approach was also tested in three further FV intervention studies conducted by the same 9 
research team, with less strict dietary control (FV provided and no supervised meals).   10 
Results: The combined model containing all carotenoids and vitamin C was a better fit than either the 11 
vitamin C only (P<0.001) model or the lutein only (P=0.006) model in the BIOFAV study.  The C-12 
statistic was slightly lower in the lutein only model (0.85) and in the model based upon factor analysis 13 
(0.88), and much lower in the vitamin C model (0.68) compared with the full model (0.95). Results for 14 
the other studies were similar, although the differences between the models were less marked.   15 
Conclusions: Although there was some variation between studies, which may relate to the level of 16 
dietary control or participant characteristics, a combined biomarker approach to assess overall FV 17 
consumption may more accurately predict FV intake within intervention studies than the use of a 18 
single biomarker.  The generalisability of these findings to other populations and study designs 19 
remains to be tested. 20 
Keywords: fruit; vegetables; dietary intake; biomarkers; methodology  21 
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Introduction 22 
Increased intake of fruit and vegetables (FV) has consistently been associated with reduced chronic 23 
disease risk in observational studies [1], which have been subjected to meta-analysis [2,3].  Such 24 
observational evidence has been supplemented by recent randomised controlled trials testing the effect 25 
of increased FV intake on clinically relevant endpoints [4-8]. 26 
 27 
In both epidemiological research and interventional studies, the accurate measurement of FV 28 
consumption is crucial. Traditional self-reported questionnaire-based approaches to the measurement 29 
of FV consumption, for example, food frequency questionnaires, 24 hour dietary recalls or food 30 
diaries, have well-reported inaccuracies [9-11]. Given such constraints, alternative, objective measures 31 
of dietary intake of FV would be valuable. Nutritional biomarkers in biological samples, such as blood 32 
and urine, may offer an objective indicator of FV intake [9]. The use of biomarkers would allow a 33 
more accurate assessment of the association between FV intake and disease risk, allow population FV 34 
intakes to be confirmed, as well as facilitating the measurement of compliance within FV intervention 35 
studies [12]. 36 
 37 
In order for a biomarker to be an accurate and valid indicator of FV intake, there are a number of 38 
requirements that must be satisfied. Biomarkers of FV intake need to be minimally invasive to 39 
participants, have the ability to discriminate between different FV intakes, be easy to measure, 40 
reproducible, and be highly responsive to any change in FV intake [13-15]. 41 
 42 
Suggested possible biomarkers of FV intake include plasma vitamin C, carotenoids and flavonoids 43 
[16-20]. In a recent systematic review [15] vitamin C and carotenoids were the two biomarkers that 44 
were most frequently measured and consistently responsive within dietary FV interventions. Some 45 
single biomarkers have been shown to be strong indicators of specific single FV, for example the 46 
carotenoid lycopene is a good predictor of tomato intake [21]. However, while some of these proposed 47 
biomarkers have been associated with a specific fruit or vegetable, or FV class, they have been less 48 
reliably associated with overall FV consumption [17-19, 22-26]. This is likely to be due, at least in 49 
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part, to FV being a complex food group with variability in the bioactive compounds contained within 50 
individual FV. Therefore, measuring a panel of potential biomarkers of FV intake within FV 51 
intervention studies has been recommended [15].  Examining this panel in an integrated way may 52 
more reliably predict overall FV consumption than a single individual biomarker or panel of individual 53 
biomarkers.  54 
 55 
This paper examines the effect of increased FV intake on a panel of biomarkers of FV consumption 56 
(vitamin C and six carotenoids), considered both singly and in combination. Using data from a strictly 57 
controlled randomised FV intervention study (BIOFAV) designed for this purpose, i.e. with strict 58 
dietary control to ensure compliance, and three further FV intervention studies, we sought to 59 
determine whether a combined biomarker approach was better at predicting overall FV intake within 60 
FV intervention studies than single biomarkers.  61 
 62 
Subjects and Methods 63 
The Biomarkers of Fruit and Vegetables (BIOFAV) study was a randomised controlled FV feeding 64 
study (2, 5 or 8 portions of FV per day for 4 weeks) in healthy volunteers (n=30).  The study was 65 
approved by the School of Medicine, Dentistry and Biomedical Sciences research ethics committee of 66 
Queen’s University Belfast and participants gave informed written consent.  The study was registered 67 
at clinicaltrials.gov as NCT01591057.  The study duration was chosen to be long enough to allow the 68 
proposed biomarkers to change in response to the alteration in FV intake, whilst the inclusion and 69 
exclusion criteria ensured a broad range of ages and healthy volunteers were included, to maximise 70 
generalisability of study findings.  A sample size of n=10 per group was chosen for two reasons, firstly 71 
because variability data from previous studies suggested that statistically significant increases in 72 
blood-based FV biomarkers would be achieved with such a sample size, whilst this was also 73 
achievable from a manpower perspective, given the intensity of the dietary intervention. 74 
 75 
Participants were recruited using university intranet emails and posters between June 2011 and May 76 
2012.  Inclusion criteria were: aged between 18 and 65 y; current consumption of FV ≤ two portions/d, 77 
5 
 
while exclusion criteria were: body mass index >35 kg/m2; use of high dose vitamins, minerals or 78 
dietary supplements likely to affect biomarkers of FV intake; excessive alcohol consumption (defined 79 
as >28 units/week for males and >21 units/week for females); food sensitivities or allergies that would 80 
interfere with the tolerance of a high FV-rich diet; current smoking; medical conditions or dietary 81 
restrictions that would considerably limit the participant’s ability to complete the study requirements; 82 
history of diabetes; pregnant or lactating; following a weight loss diet.  Participants’ usual diet was 83 
assessed using the 7-day diet history method.   84 
 85 
Participants were randomly assigned, using a block design, to one of three intervention groups, to 86 
consume 2, 5 or 8 portions of FV daily for 4 weeks.  87 
 88 
All food, including the FV consumed during the intervention, was provided and there was supervised 89 
consumption of two meals per day on weekdays. The menu plan was based around the participant’s 90 
portions allocation, their likes and dislikes and also their usual energy intakes.  Participants were 91 
therefore free to choose the FV they wished to consume, although a balance of fruit versus vegetables 92 
was encouraged, and variety also promoted.  A portion of FV was as recommended by Department of 93 
Health (UK) guidelines, e.g. one apple, orange or banana, 3 heaped tablespoons of vegetables, or 150 94 
ml fruit juice) [27].   95 
 96 
A fasting blood sample was collected from all participants at baseline and week 4. All bloods were 97 
processed within two hours of being drawn and stored at -80C. Weight and height were also assessed 98 
at baseline and week 4, and weight was re-measured at week 2 to ensure it remained constant over the 99 
course of the study, and diets were altered if weight loss or gain was observed.  Demographic 100 
information was collected on alcohol consumption, smoking status, levels of physical activity (MRC 101 
Recent Physical Activity Questionnaire), medication use at baseline and week 4 to ensure there were 102 
no changes to these behaviours over the study duration. 103 
 104 
Other fruit and vegetable intervention studies 105 
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The other FV intervention studies included in the current analysis were randomised interventions, 106 
conducted in a similar way to BIOFAV, and by the same research team, except the intervention was 107 
less strictly controlled, i.e. FV were provided to the participants rather than whole diet, and there was 108 
no supervised consumption.  The FAVRIT study randomised participants with hypertension to 1, 3 or 109 
6 portions of FV/d for 8 weeks, the ADIT study randomised participants >65 y to 2 or 5 portions of 110 
FV/d for 16 weeks, while the FIRST study recruited participants at increased risk of CVD and 111 
randomised them to 2, 4 or 7 portions FV/d for 12 weeks.  Detailed methodology and analysis of the 112 
primary outcomes of these studies have been published [5,7-8], and the studies are summarised in 113 
Table 1. 114 
 115 
Laboratory analysis 116 
All biomarker analysis was conducted blinded to allocated FV group.  For all studies, plasma ascorbic 117 
acid concentrations were determined by fluorometric assay [28]. Serum concentrations of lutein, 118 
zeaxanthin, β-cryptoxanthin, α-carotene, β-carotene and lycopene were measured by reverse phase 119 
high performance liquid chromatography (HPLC) [29]. Assays were standardised against appropriate 120 
National Institute of Standards and Technology reference materials.  These assays are also externally 121 
quality assured by participation in the French Society for Vitamins and Biofactors quality assurance 122 
scheme.  123 
 124 
Statistical Analysis 125 
For baseline characteristics continuous variables are presented as mean (SD) and categorical variables 126 
are presented as n (%). Between groups comparisons of baseline characteristics were made using one 127 
way ANOVA tests for continuous variables and Chi-square tests for categorical variables. 128 
 129 
Biomarker status variables were summarised as mean (standard deviation) and changes are expressed 130 
as mean (95% CI). Changes in micronutrient status were assessed using one-way ANOVA, with a test 131 
for linear trend across groups if there were > two intervention groups. 132 
 133 
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In BIOFAV, ordinal (proportion odds) logistic regression analyses were utilised to predict allocated 134 
FV group (2, 5 or 8 portions of FV per day).  Initially, models were fitted with single biomarkers 135 
(vitamin C only, lutein only) and then a combined biomarker model was fitted (containing all 136 
carotenoids and vitamin C).  Biomarker variables entered into models were based upon change 137 
between week 4 and baseline and were standardised to calculate (adjusted) odds ratios (OR) per 138 
standard deviation increase in each variable and 95% confidence intervals (95% CI).  To avoid 139 
computational problems when calculating, for the full model, an optimism corrected C-statistic 140 
(described later), a separate model was created in which factor analysis (based upon the principal-141 
factor method, including 2 factors and no rotation) was first used to reduce the carotenoid variables to 142 
produce two factor score variables.  These two factor score variables were entered into a model along 143 
with vitamin C.  The combined biomarker model was formally compared to the models with vitamin C 144 
and lutein model using likelihood ratio tests.  The proportional odds assumption was informally 145 
checked by comparing the estimates from logistic regression models comparing 2 to 5 items of FV 146 
intake per day and 5 to 8 items of FV intake per day.      147 
 148 
The ability of the models to correctly classify FV intake (i.e. 2, 5 or 8 portions of FV per day) were 149 
measured by creating 3 by 3 tables of predicted intake based upon the model scores against the 150 
observed intake (i.e. the actual category of intake).  The cut offs for the predicted intake categories 151 
were chosen post-hoc to obtain the correct total number of predicted cases for each outcome category 152 
overall.  Based upon these 3 by 3 tables, the percentage agreement of predicted and observed intake 153 
and a weighted Kappa value was calculated.  154 
 155 
The discriminative ability of each model was formally quantified using a C-statistic.  C-statistics and 156 
confidence intervals were calculated using STATA add-on somersd [30]. This statistic can be 157 
interpreted as the probability that, for a pair of individuals with different FV category intake, the one 158 
in the higher FV intake category has higher predicted probability for that category from the model.  159 
Bootstrap methods were applied to attempt to correct for over-fitting. Specifically, each model was 160 
estimated in a bootstrap sample and the modified C-statistic was calculated in the bootstrap sample 161 
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and in the original sample. This process was repeated 200 times and the average difference in 162 
performance in the bootstrap sample and in the original sample was calculated (the optimism) and 163 
subtracted from the apparent performance to estimate the internally validated performance [31].   164 
 165 
These analyses were replicated in FIRST (using ordinal logistic regression models with outcome 2, 4 166 
and 7 FV per day and explanatory variables based upon the difference in biomarker levels from 167 
baseline to week 12) and FAVRIT (using ordinal logistic regression models with outcome 1, 3 and 6 168 
FV per day and using explanatory variables based upon the difference in biomarker levels from 169 
baseline to week 8).  In ADIT similar analyses were conducted using logistic regression, as only two 170 
FV intake categories were used (2 and 5 FV per day), with explanatory variables based upon 171 
difference in biomarker from baseline to week 16.   172 
 173 
These analyses were conducted to predict allocated FV group, but, because of the reduced dietary 174 
control in these studies (supply of FV and close contact with study team to encourage compliance), it 175 
is possible that compliance with the dietary intervention in these other studies was less than in 176 
BIOFAV.  Linear regression analysis with self-reported FV intake as the outcome was therefore also 177 
used to calculate an adjusted R2 value for models containing change in vitamin C alone, lutein alone 178 
and a combination of all carotenoids and vitamin C in FAVRIT, FIRST and ADIT. 179 
 180 
Statistical analyses were performed using SPSS version 19.0 for Mac (SPSS Inc, Chicago, IL) and 181 
STATA version 12 (StataCorp, College Station, Texas).  182 
 183 
Results 184 
A total of 30 participants completed the BIOFAV study.  Figure 1 shows the flow of participants 185 
through the study.  One participant had a missing blood sample at week 4.  Table 2 shows the baseline 186 
study population characteristics. Also shown in table 2 are the baseline characteristics according to FV 187 
intervention group (2, 5 or 8 portions FV/d). The baseline characteristics were similar in the three FV 188 
intervention groups (2, 5 or 8 portions FV/d). 189 
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 190 
Table 3 shows baseline and change in biomarker status in the three FV intervention groups. The 191 
groups were similar at baseline, but there were statistically significant between group changes in all 192 
biomarkers measured at week 4, with the exception of zeaxanthin and lycopene, although a similar 193 
trend was observed for zeaxanthin. 194 
 195 
Table 4 illustrates the single and combined biomarker models used to predict allocated FV group in 196 
BIOFAV participants.  In the vitamin C only model, vitamin C was associated with FV group, whilst 197 
in the lutein only model, lutein was also associated with FV group. Formal tests indicated that the 198 
combined model containing all carotenoids and vitamin C was a better fit than either the vitamin C 199 
only (P<0.001) model or the lutein only (P=0.006) model.  The combined model correctly allocated 200 
86% of individuals to the correct group compared with 52% in the vitamin C only model and 66% in 201 
the lutein only model.  These corresponded to Kappa values of 0.85 in the combined model compared 202 
with 0.31 in the vitamin C only and 0.54 in the lutein only models.  The C-statistic was slightly lower 203 
in the lutein only model (0.84) and in the model based upon factor analysis (0.88), and much lower in 204 
the vitamin C model (0.68) compared with the full model (0.95). An optimism corrected C-statistic 205 
was not calculable for the full model, however correction for optimism reduced the C-statistic for the 206 
factor analysis model (0.85) but the C-statistics for the vitamin C model and lutein model were little 207 
altered (0.68 and 0.84).  208 
  209 
Results for the other studies are shown in Table 5, but the differences between the models were less 210 
marked.  For instance, the optimism corrected C-statistics was slightly higher in the combined model 211 
compared with the vitamin C only model and lutein only model in FAVRIT (0.76, 0.64 and 0.65, 212 
respectively) and in ADIT (0.75, 0.72 and 0.67, respectively), but not in FIRST (0.64, 0.58 and 0.66, 213 
respectively).  Similarly, adjusted r2 values were higher in the combined model compared with the 214 
vitamin C only model and lutein only in FAVRIT (0.22, 0.03 and 0.16, respectively) and in ADIT 215 
(0.26, 0.12 and <0.01, respectively), but not in FIRST (0.11, <0.01 and 0.15, respectively).   216 
 217 
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When analyses were replicated to predict allocated FV group in each of the four studies based upon 218 
the final biomarker values as opposed to the change variables, similar levels of agreement were 219 
demonstrated (data not shown). 220 
 221 
Discussion 222 
This study suggests that a combined biomarker panel may better predict FV intake within intervention 223 
studies than consideration of single biomarkers.  Plasma vitamin C, and certain carotenoids and 224 
flavonoids have been suggested as biomarkers of intake of overall FV [16-20, 23-24, 26, 32-34]. A 225 
systematic review of FV biomarkers within FV intervention studies showed that vitamin C and 226 
carotenoids are commonly used and do tend to increase [15].  However, there are two problems with 227 
the assessment of these biomarkers of overall FV intake: firstly FV is a complex food group, and the 228 
content of phytochemicals proposed as biomarkers will vary markedly between different classes of 229 
FV, and even within different varieties of the same FV [35-37].  Storage and processing of FV can 230 
also affect phytochemical content [38].  Secondly, there are a number of factors that will affect 231 
biomarker response to a given FV intake, including inter-individual variation in digestion, absorption 232 
and metabolism. Some of this variation will be genetic in origin, but environmental factors such as 233 
BMI [39], smoking [40], baseline biomarker status [41,42] and other aspects of diet (e.g. fat content of 234 
meal in which FV are consumed [24, 43-46]) will affect bioavailability of the phytochemicals and/or 235 
biomarker response. Nutritional biomarkers will therefore never be perfect at reflecting dietary FV 236 
consumption on their own, because physiological processes in the body will also impact upon 237 
response.  Furthermore, there are other dietary sources of some of these compounds and therefore 238 
single compounds may not reflect total overall FV consumption.  In addition, the plasma concentration 239 
of vitamin C has a linear relationship with vitamin C intake up until a specific point, above which 240 
plasma concentrations of vitamin C plateau (>5 servings of FV) [19,47], and therefore vitamin C may 241 
be a less useful biomarker at higher levels of intake.  242 
 243 
Despite these limitations, efforts to improve the ability of biomarkers to predict FV intake would be 244 
valuable in nutritional epidemiology.  Campbell et al, [26] initially suggested combining biomarkers, 245 
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and summing carotenoid status [48] or flavonoid urinary excretion [49-51] has previously been 246 
attempted.  Such an approach, however, will take greater account of the more predominant compounds 247 
(e.g. lycopene when summing total carotenoids), and therefore a more sophisticated approach may be 248 
required.  A recent publication has conducted a similar analysis to that performed here in a single, less 249 
well-controlled FV intervention [52]. 250 
 251 
Because of the limitations of the FV biomarkers when examining overall FV intake, we proposed that 252 
a combined biomarker approach (vitamin C and six carotenoids) may be able to take into account the 253 
diversity and variety of bioactive compounds found within FV and would be more likely to capture the 254 
total amount of FV consumed.  The analyses utilised a tightly controlled FV intervention study 255 
(BIOFAV) and three previously-conducted, less tightly controlled FV interventions (FAVRIT, FIRST 256 
and ADIT).  The combined biomarker model performed better in the more tightly controlled 257 
intervention, BIOFAV. Similar patterns of results were observed for the other studies, but differences 258 
between the combined biomarker and individual biomarker models were less marked, and this was 259 
particularly true for the FIRST study, where the combined model was not significantly better than the 260 
lutein only model. This suggests that an integrated panel of biomarkers in intervention studies may 261 
obtain a more accurate and precise measure of total FV consumption, but the observed differences 262 
detected between studies do need to be explored. 263 
 264 
It is likely that the difference detected within the current studies arose due to the less intensive and less 265 
dietary control in the other three dietary interventions compared to BIOFAV, although efforts were 266 
made in each of these other interventions to maximise compliance with the allocated intervention and 267 
minimize inaccuracies in self-reporting. For example, FV was delivered to the participants in all three 268 
studies, participants were contacted weekly by telephone to monitor compliance with the intervention 269 
study, and participants were encouraged to report any lack of compliance with the intervention.  It is 270 
possible that there was a lack of adherence to the dietary intervention, and therefore the analysis 271 
according to allocated FV group would not have been appropriate.  However, the association between 272 
biomarker response and self-reported FV intake (in portions/d) was also calculated and revealed 273 
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similar associations.  It is still possible that the self-reported measures utilised to assess numbers of 274 
portions of FV consumed were inaccurately reported.  There may also have been between-study 275 
differences in the FV self-selected by participants or in the composition of the FV consumed, which 276 
could have impacted on biomarker responses.  For example, the range of FV consumed within 277 
BIOFAV may have been less broad than in the other studies, although this is unlikely, and similar 278 
guidance regarding selection of FV (a balance of FV, encouragement to maximise variety) was given 279 
in all studies.  Similarly, the FV supplier was the same in all studies, and all fieldwork duration 280 
periods were long enough to account for between-study seasonal differences in FV composition.  281 
Another major difference between BIOFAV and other FV intervention studies was that BIOFAV 282 
recruited young healthy individuals, whilst the other studies recruited either older participants or those 283 
at high CVD risk.  BIOFAV participants were non-smokers, and had BMIs in the normal range, 284 
whereas those in the other studies included smokers, and participants were overweight.  It is possible 285 
that there is an age-related reduction in FV biomarker response, or that biomarker responses are 286 
reduced with increasing weight [39] and in smokers [40] and that this contributed to the differences 287 
observed.  288 
 289 
The analyses presented here have several strengths.  They are the first to examine combining FV 290 
biomarkers to improve prediction of FV intake in a tightly controlled intervention, or other than simple 291 
summation [48-51].  The BIOFAV study was strictly controlled, and we are confident that participants 292 
consumed the number of FV portions they were allocated to, therefore our observation of improved 293 
prediction of FV intake using a combined panel of biomarkers is novel and robust.  The ability to test 294 
this hypothesis in further FV interventions is also a strength.  There are, however, some accompanying 295 
limitations – the overall absolute performance of the model to predict intake, particularly in the less 296 
controlled studies, was relatively low (e.g. an r2 of 0.26 in ADIT), indicating there is substantial 297 
variability in FV intake not explained by the included biomarkers, and that what we are commenting 298 
on is the relative improvement with a combined biomarker approach.  A further limitation is that 299 
internal validation was not possible for the combined model in BIOFAV, due to the small number of 300 
observations relative to the parameters estimated, and therefore it was not possible to correct for over 301 
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fitting/optimism in the models.  Although internal validation was performed for the other models, a 302 
better estimate of the prognostic power of these models would be determined using external 303 
validation.  The combined biomarker approach could be extended and incorporate further biomarkers 304 
(e.g. flavonoids) and account for environmental factors that could affect biomarker response (e.g. 305 
BMI, smoking), while the ability of such an approach, compared with single biomarkers, to predict 306 
individual intakes on a population level would require further model development and testing.  The 307 
utility of a combined biomarker approach to predict different patterns of FV intake (e.g. predominantly 308 
fruit or vegetable) or diets containing different classes of FV (e.g. green vegetables, root vegetables, 309 
pulses, fruits), or different varieties of the same FV classes could also be explored.  A combination of 310 
multiple measures of dietary assessment may provide more accurate estimates of true dietary intake, 311 
for example combining biomarkers and self-reported measures of dietary intake using regression 312 
calibration equations [53,54], and this could represent a natural extension of combining biomarkers 313 
when measuring FV intake. The biomarkers measured here are commonly used in FV intervention 314 
studies and therefore the suggested approach, if confirmed as useful, would be at no extra cost.   315 
 316 
In conclusion, there was some evidence that a combined model including a range of FV biomarkers (a 317 
carotenoid panel and vitamin C) performed better at predicting allocated FV within a strictly 318 
controlled dietary intervention study than the use of a model with vitamin C only or lutein only. A 319 
similar pattern was observed in three less intensive FV interventions, although differences between 320 
models were less clear cut.  Therefore, a combined biomarker approach to assess overall FV 321 
consumption may more accurately predict FV intake within intervention studies than the use of single 322 
biomarkers.  The utility of such an approach to predict population level intake of FV remains to be 323 
tested. 324 
 325 
 326 
 327 
 328 
 329 
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Study 
Number of 
participants 
completing 
intervention Study Duration Portions/d 
Dietary intervention 
intensity Age (y) Health Status 
Assessment visits when 
blood collected 
BIOFAV 30 
4 weeks (no wash out required as 
1-2 portions/day FV consumers 
recruited) 2, 5 or 8 
All food provided, 
including FV.  Two 
meals/d consumed 
under supervision. 18-65 Healthy 0, 2 and 4 weeks 
FIRST [5] 89 12 weeks (+4 week run-in-period) 2, 4 or 7 
FV supplied weekly.  
Compliance encouraged 
by weekly telephone 
call. 40-77 High risk of CVD 
0 and 12 weeks of 
intervention period 
FAVRIT [8] 117 8 weeks (+4 week run-in-period) 1, 3 or 6 
FV supplied weekly.  
Compliance encouraged 
by weekly telephone 
call. 40-65 Hypertensive 
0 and 8 weeks of 
intervention period 
ADIT [6,7] 82 
16 weeks (no wash out required as  
≤ 2 portions/day FV consumers 
recruited) 2 or 5 
FV supplied weekly.  
Compliance encouraged 
65-85 Healthy 0, 6, 12 and 16 weeks 
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Table 1. Summary details of the intervention studies included in the combined biomarker analysis. 
  
by weekly telephone 
call. 
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Table 2. Baseline characteristics of BIOFAV participants (n=30) according to FV intervention group 
 
 
 
 
 
 
 
 
 
 
 
aContinuous variables presented as mean (SD). bCategorical variables presented as n(%).  
  
Participant Characteristic Total 2 portion group (n=11) 5 portion group (n=9) 8 portion group (n=10)  
Age (years)a 28.5 (11.8) 25.9 (10.8) 28.2 (9.6) 31.7 (14.9)  
Sex n (% female) b 15 (50) 6 (54.5) 4 (44.4) 5 (50)  
Weight (kg)a 69.7 (13.7) 70.9 (17.8) 70.4 (8.6) 67.8 (13.5)  
Height (m)a 1.70 (0.1) 1.70 (0.1) 1.7 (0.1) 1.69 (0.07)  
BMI (kg/m2)a 24.0 (4.1) 24.6 (5.4) 23.8 (2.7) 23.7 (3.6)  
Waist (cm)a 81.7 (12.2) 82.0 (13.8) 83.7 (11.2) 79.6 (12.0)  
Hip (cm)a 100.7 (6.9) 101.5 (8.9) 100.6 (5.2) 99.8 (6.3)  
Systolic blood pressure (mmHg)a 109.6 (29.2) 109.3 (23.7) 107.1 (32.2) 112.2 (34.5)  
Diastolic blood pressure (mmHg)a 72.7 (21.6) 74.8 (22.1) 70.6 (23.8) 72.3 (21.2)  
Past smoker n (%)b 6 (20) 2 (18.2) 2 (22.2) 2 (20.0)  
Alcohol consumers n (%)b 22 (73.4) 9 (81.8) 7 (77.8) 6 (60.0) 
   Never or occasionally 8 (26.7) 2 (18.2) 2 (22.2) 4 (40.0) 
  Once or twice a week 20 (66.7) 9 (81.8) 6 (66.7) 5 (50.0) 
  Three to five times a week 2 (6.7) 0 (0) 1 (11.1) 1 (10.0) 
Full time education (years)a 16.1 (2.8) 15.9 (1.5) 16.2 (3.1) 16.3 (3.8)  
Using medication n (%)b 13 (43.3) 4 (36.4) 5 (55.6) 4 (40.0)  
Employmentb     
   Student 18 (60) 8 (72.7) 4 (44.4) 6 (60) 
  Full time employment 11 (36.7) 3 (27.3) 4 (44.4) 4 (40) 
  Unemployed 1 (3.3) 0 (0) 1 (11.1) 0 (0) 
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Table 3. Serum and plasma FV biomarker status of BIOFAV participants at baseline and during 
intervention in those consuming 2, 5 or 8 portions of FV/d 
  n Baseline Change at 4 wk 
Vitamin C (mol/l) 2 portions/d 11 58.4 (16.3) -7.7 (-20.9,5.5) 
 5 portions/d 9 61.0 (13.1) 14.0 (2.9,25.1) 
 8 portions/d 9 52.6 (20.5) 11.7 (-6.7,30.0) 
 P-value  0.45 0.04 
Lutein (mol/l) 2 portions/d 11 0.16 (0.07) -0.01 (-0.03,0.01) 
 5 portions/d 9 0.15 (0.05) 0.03 (0.02,0.05) 
 8 portions/d 9 0.16 (0.03) 0.06 (0.03,0.08) 
 P-value  0.89 <0.001 
Zeaxanthin (mol/l) 2 portions/d 11 0.04 (0.02) 0.002 (-0.003,0.006) 
 5 portions/d 9 0.05 (0.02) 0.006 (0.003,0.009) 
 8 portions/d 9 0.05 (0.01) 0.008 (-0.002,0.018) 
 P-value  0.69 0.11 
-cryptoxanthin 
(mol/l) 
2 portions/d 11 0.10 (0.09) -0.01 (-0.03,0.02) 
 5 portions/d 9 0.08 (0.04) 0.03 (0.004,0.06) 
 8 portions/d 9 0.08 (0.02) 0.06 (0.01,0.11) 
 P-value  0.41 0.005 
-carotene (mol/l) 2 portions/d 11 0.14 (0.10) 0.08 (0.02,0.14) 
 5 portions/d 9 0.10 (0.06) 0.13 (0.03,0.23) 
 8 portions/d 9 0.13 (0.08) 0.34 (0.13,0.54) 
 P-value  0.80 0.003 
-carotene (mol/l) 2 portions/d 11 0.34 (0.25) 0.14 (0.01,0.26) 
 5 portions/d 9 0.24 (0.19) 0.36 (0.05,0.67) 
 8 portions/d 9 0.48 (0.44) 0.88 (0.31,1.46) 
 P-value  0.33 0.002 
Lycopene (mol/l) 2 portions/d 11 0.51 (0.26) 0.064 (-0.032,0.159) 
 5 portions/d 9 0.37 (0.18) 0.102 (-0.071,0.276) 
 8 portions/d 9 0.48 (0.26) 0.003 (-0.218,0.224) 
 P-value  0.80 0.55 
Values are mean (SD) with changes expressed as mean (95% CI).  Change calculated as wk 4 – baseline.  Both 
baseline variables and changes were compared between 2, 5 and 8 portions/d groups using one way analysis of 
variance with linear trend fitted.   
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Table 4. Ordinal logistic regression to predict allocated FV group in BIOFAV participants utilising single or combined biomarker models 
  Vitamin C only model Lutein only model 
All carotenoids and 
vitamin C model  
Factor analysis model 
(all Carotenoids) 
 
 OR (95% CI) P  OR (95% CI) P  OR (95%CI)  P  OR (95% CI) P  
Estimatesa: 
OR (95% 
CI) per 
standard 
deviation 
increase  
Vitamin C 2.45 (1.09, 5.54) 0.03   1.87 (0.51, 6.93) 0.35 1.59 (0.65, 3.87) 0.312 
Lutein                 8.18 (2.19, 30.54) 0.002 30.75 (1.28, 736.55) 0.04   
Zeaxanthin     0.23 (0.02, 2.46) 0.23   
Lycopene     0.32 (0.09, 1.11) 0.07   
β-cryptoxanthin      4.11 (0.49, 34.48) 0.19   
α-carotene      1.82 (0.04, 92.06) 0.77   
β-carotene      2.19 (0.04, 107.34) 0.69   
First factor (footnote)b       12.71 (2.88, 56.04) 0.001 
Second Factor (footnote)c       2.28 (0.73, 7.14) 0.157 
Model 
Performanc
e 
P value compared with full modeld <0.001  0.006  Reference  <0.001  
Percentage agreement e 52 % (15/29)  66 % (19/29)  86 % (25/29)  75 % (22/29)  
Weighted Kappa 0.31  0.54  0.85  0.69  
C-statistic 0.68 (0.50, 0.86)  0.84 (0.71, 0.96)  0.95 (0.89, 1.00)  0.88 (0.76, 1.00)  
Optimism corrected C-statistic 0.68  0.84  f  0.85  
a Estimates based upon ordinal logistic regression with outcome intake in groups (2, 5 and 8 portions per day) and explanatory variables change in biomarker values at 4 
weeks. 
bFirst factor calculated from factor analysis based upon all carotenoids (change at 4 weeks).  Calculate score= 0.22 X Lutein + 0.20 X Zeaxanthin + 0.02 X Lycopene + 0.09 X 
β-cryptoxanthin + 0.16 X α-carotene + 0.62 X β-carotene. 
cSecond factor calculated from factor analysis based upon all carotenoids (change at 4 weeks).  Calculate score= 0.41 X Lutein + 0.30 X Zeaxanthin + 0.04 X Lycopene + 0.14 
X β-cryptoxanthin + -0.52 X α-carotene + -0.11 X β-carotene. 
d P value for likelihood ratio test comparing each model to model containing all carotenoids and vitamin C  
e Comparing actual category of intake with predicted category of intake based upon model cut offs (chosen to obtain the correct proportion in each category of intake). 
f Optimism could not be calculated due to large number of parameters compared with number of observations. 
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Table 5. Regression analysis to predict allocated FV group in FAVRIT, FIRST and ADIT 
studies utilising single or combined biomarker model approach 
   Vitamin C model Lutein model 
All carotenoids and 
vitamin C model  
FAVRIT studya 
Estimates: OR 
(95% CI) per 
standard 
deviation 
increase  
Vitamin C 1.53 (1.05, 2.24)  1.71 (1.14, 2.56) 
Lutein   2.15 (1.40, 3.30) 1.69 (0.87, 3.27) 
Zeaxanthin    0.68 (0.32, 1.41) 
Lycopene    0.52 (0.30, 0.91) 
β-cryptoxanthin     6.23 (2.65, 14.63) 
α-carotene     1.33 (0.60, 2.94) 
β-carotene      0.60 (0.27, 1.32) 
Model 
Performance 
P compared with full modeld <0.001 <0.001 Reference  
Percentage agreement e  41% (41/100) 44% (44/100) 61 % (61/100) 
Weighted Kappa 0.21 0.24 0.47 
C-statistic 0.64 (0.55, 0.73) 0.65 (0.57, 0.74) 0.80 (0.71, 0.88) 
Optimism corrected C-statistic 0.64 0.65 0.76 
Adjusted r2 f 0.03 0.16 0.22 
FIRST studyb 
Estimates: OR 
(95% CI) per 
standard 
deviation 
increase  
Vitamin C 1.14 (0.77, 1.69)  0.98 (0.64, 1.49) 
Lutein   1.96 (1.25, 3.08) 2.89 (1.30, 6.46) 
Zeaxanthin    0.25 (0.05, 1.13) 
Lycopene    0.89 (0.53, 1.52) 
β-cryptoxanthin     2.48 (1.09, 5.63) 
α-carotene     2.61 (0.23, 29.30) 
β-carotene      0.77 (0.36, 1.64) 
Model 
Performance 
P compared with full modeld 0.02 0.40  Reference  
Percentage agreement e 40 % (33/83) 41 % (34/83) 45 % (37/83) 
Weighted Kappa 0.12 0.19 0.30 
C-statistic 0.58 (0.48, 0.68) 0.66 (0.57, 0.75) 0.70 (0.61, 0.79) 
Optimism corrected C-statistic 0.58 0.66 0.64 
Adjusted r2 f <0.01 0.15 0.11 
ADIT studyc 
Estimates: OR 
(95% CI) per 
standard 
deviation 
increase  
Vitamin C 2.39 (1.37, 4.17)  2.37 (1.24, 4.54) 
Lutein   1.70 (0.99, 2.93) 1.59 (0.74, 3.43) 
Zeaxanthin    2.76 (0.25, 30.63) 
Lycopene    1.03 (0.50, 2.12) 
β-cryptoxanthin     1.91 (0.94, 3.92) 
α-carotene     5.08 (0.62, 41.71)  
β-carotene      0.28 (0.10, 0.74) 
Model 
Performance 
P compared with full modeld 0.02 <0.001 Reference   
Percentage agreement e 70 % (55/79) 62 % (49/79) 75 % (59/79) 
Kappa 0.39 0.24 0.49 
C-statistic  0.73 (0.62, 0.84) 0.68 (0.56, 0.80) 0.82 (0.72, 0.91) 
Optimism corrected C-statistic  0.72 0.67 0.75 
Adjusted r2 f 0.12 <0.01 0.26 
a Estimates based upon ordinal logistic regression with outcome intake in groups (1, 3 and 6 portions per day) 
and explanatory variables change in biomarker values at 8 weeks. 
b Estimates based upon ordinal logistic regression with outcome intake in groups (2, 4 and 7 portions per day) 
and explanatory variables change in biomarker values at 12 weeks. 
c Estimates based upon logistic regression with outcome intake in groups (2 and 5 portions per day) and 
explanatory variables change in biomarker values at 16 weeks. 
d P value for likelihood ratio test comparing each model to model containing all carotenoids and vitamin C. 
e Comparing actual category of intake with predicted category of intake based upon  model cut offs, chosen to 
obtain the correct proportion in each category of intake. 
f Adjusted r2 calculated using multiple linear regression with actual self-reported FV intake as the outcome and 
change in biomarker values as explanatory variables.  
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Legends for figures 
 
Figure 1:  Flow chart illustrating recruitment, randomisation and participants’ progression 
through BIOFAV dietary intervention study. 
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44 not eligible  
11 no reply 
12 suitable but did not wish to participate 
32 participants gave consent  
1 withdrawal due to 
other commitment 
31 participants completed baseline 
assessment 
Recruitment and 
Screening 
Randomisation 
Baseline Fasting blood sample 
  Anthropometry 
  Questionnaires 
2 portions/d 5 portions/d 8 portions/d 
11 randomised  10 randomised  10 randomised  
1 withdrawal - 
exclusion 
criteria 
Week 4 Repeat of baseline 
assessments  
4 week intensive dietary intervention completed 
99 participants approached 
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11 completed 9 completed 10 completed  
